Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122022562 | 12202256 | 2 | F | 20160118 | 20160708 | 20160322 | 20160721 | EXP | DE-TEVA-644198GER | TEVA | 53.00 | YR | M | Y | 100.00000 | KG | 20160722 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122022562 | 12202256 | 1 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | N | 76052 | 40 | MG | ||||||||
| 122022562 | 12202256 | 2 | C | bisohexal | BISOPROLOL FUMARATE | 1 | 5 MILLIGRAM DAILY; | U | 0 | 5 | MG | QD | |||||||
| 122022562 | 12202256 | 3 | C | codiovan 160/12.5 mg | 2 | 1X1/2 | U | 0 | |||||||||||
| 122022562 | 12202256 | 4 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 300 MILLIGRAM DAILY; | U | 0 | 300 | MG | QD | |||||||
| 122022562 | 12202256 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 1000 MILLIGRAM DAILY; | N | 0 | 500 | MG | BID | |||||||
| 122022562 | 12202256 | 6 | C | sitagliptin | SITAGLIPTIN | 1 | 100 MILLIGRAM DAILY; | U | 0 | 100 | MG | QD | |||||||
| 122022562 | 12202256 | 7 | C | doxepin | DOXEPIN | 1 | 25 MILLIGRAM DAILY; | U | 0 | 25 | MG | QD | |||||||
| 122022562 | 12202256 | 8 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | U | 0 | ||||||||||
| 122022562 | 12202256 | 9 | C | liprolog | INSULIN LISPRO | 1 | Subcutaneous | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122022562 | 12202256 | 1 | Hyperlipidaemia |
| 122022562 | 12202256 | 2 | Hypertension |
| 122022562 | 12202256 | 3 | Hypertension |
| 122022562 | 12202256 | 4 | Hyperuricaemia |
| 122022562 | 12202256 | 5 | Diabetes mellitus |
| 122022562 | 12202256 | 6 | Diabetes mellitus |
| 122022562 | 12202256 | 7 | Depression |
| 122022562 | 12202256 | 8 | Diabetes mellitus |
| 122022562 | 12202256 | 9 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122022562 | 12202256 | HO |
| 122022562 | 12202256 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122022562 | 12202256 | Acute kidney injury | |
| 122022562 | 12202256 | Dialysis | |
| 122022562 | 12202256 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |